643 related articles for article (PubMed ID: 8182706)
21. Synthesis, characterization, and antitumor activity of new chloroethylamine platinum complexes.
Khokhar AR; Xu Q; Newman RA; Kido Y; Siddik ZH
J Inorg Biochem; 1992 Feb; 45(3):211-9. PubMed ID: 1634893
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biodistribution and antitumor activity of hematoporphyrin-platinum(II) conjugates.
Kim YS; Song R; Hyun Kim D; Jun MJ; Sohn YS
Bioorg Med Chem; 2003 Apr; 11(8):1753-60. PubMed ID: 12659761
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization, and antitumor activity of water-soluble aminoalkanol platinum(II) complexes.
Khokhar AR; Xu QY; Newman RA; Siddik ZH
J Inorg Biochem; 1991 Jul; 43(1):57-63. PubMed ID: 1940901
[TBL] [Abstract][Full Text] [Related]
24. A new family of water-soluble, third generation antitumor platinum complexes.
Bitha P; Carvajal SG; Citarella RV; Delos Santos EF; Durr FE; Hlavka JJ; Lang SA; Lindsay HL; Thomas JP; Wallace RE
J Med Chem; 1989 Sep; 32(9):2063-7. PubMed ID: 2671371
[TBL] [Abstract][Full Text] [Related]
25. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
[TBL] [Abstract][Full Text] [Related]
26. Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity.
Talebian AH; Bensely D; Schein PS; Green D
Anticancer Drug Des; 1990 Nov; 5(4):371-8. PubMed ID: 2291775
[TBL] [Abstract][Full Text] [Related]
27. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor activity of cyclotriphosphazene-(diamine)platinum(II) conjugates.
Baek H; Cho Y; Lee CO; Sohn YS
Anticancer Drugs; 2000 Oct; 11(9):715-25. PubMed ID: 11129734
[TBL] [Abstract][Full Text] [Related]
29. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
Kwon YE; Park JY; Kim WK
Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
[TBL] [Abstract][Full Text] [Related]
30. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R,2R-cyclohexanediamine-N,N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2] platinum(II).
Kawai H; Kitano Y; Mutoh M; Hata G
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):357-61. PubMed ID: 8500201
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity of platinum(II) complexes with trans-3,4-diamino-2,2,6,6-tetramethylpiperidine-1-oxyl.
Sen' VD; Golubev VA; Volkova LM; Konovalova NP
J Inorg Biochem; 1996 Oct; 64(1):69-77. PubMed ID: 8837500
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
[TBL] [Abstract][Full Text] [Related]
34. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
[TBL] [Abstract][Full Text] [Related]
35. Cellular pharmacology, antineoplastic activity and low in vivo toxicity of a carboxylato-bridged platinum(II) complex bis(acetato)diammine-bis-micro-acetato diplatinum (II) dihydrate.
Momekov G; Konstantinov S; Topashka-Ancheva M; Bakalova A; Arpadjan S; Karaivanova M
Med Chem; 2007 Mar; 3(2):157-65. PubMed ID: 17348853
[TBL] [Abstract][Full Text] [Related]
36. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
Kraker AJ; Hoeschele JD; Elliott WL; Showalter HD; Sercel AD; Farrell NP
J Med Chem; 1992 Nov; 35(24):4526-32. PubMed ID: 1335074
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.
Khokhar AR; Xu QY; Siddik ZH
J Inorg Biochem; 1990 Jun; 39(2):117-23. PubMed ID: 2380705
[TBL] [Abstract][Full Text] [Related]
38. Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
Khokhar AR; al-Baker S; Brown T; Perez-Soler R
J Med Chem; 1991 Jan; 34(1):325-9. PubMed ID: 1992134
[TBL] [Abstract][Full Text] [Related]
39. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
[TBL] [Abstract][Full Text] [Related]
40. Factor analysis of in vitro antitumor activities of platinum complexes.
Kuramochi H; Motegi A; Maruyama S; Okamoto K; Takahashi K; Kogawa O; Nowatari H; Hayami H
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):123-7. PubMed ID: 2337935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
